Hello there! Mylotarg is generally known to benefit patients specifically with favorable risk, but it also depends on the patient's AML characteristics. Here is an interview on our website explaining more about this: healthtree.org/aml/community/podcasts/attacking-aml-cells-with-new-immunotherapy-infusion (go to timestamp 13:00-19:00 on the audio or paragraphs 24-35 on the full transcript)
@funwithnoorandkabeer5605 Жыл бұрын
@@HTUforBloodCancers thanks. Can u tell me what is the meaning of leukemia custom panel (ten Marker) limited mrd...refer to bma no 1442/22
@HTUforBloodCancers Жыл бұрын
@@funwithnoorandkabeer5605 MRD panels measure the amount of cancer cells left in the body. One of these tests is flow cytometry, which is used to look for certain proteins (markers) on the cells' surface. Here is another video about it: healthtree.org/aml/university/app/courses/iQEuDMjf8rW5X4HjslEp/oDH8qAKaIGxB03O9jQ3v. Hope that helps!